BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hustoft TN, Hausken T, Ystad SO, Valeur J, Brokstad K, Hatlebakk JG, Lied GA. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2017;29. [PMID: 27747984 DOI: 10.1111/nmo.12969] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Gibson PR, Halmos EP, Muir JG. Review article: FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited. Aliment Pharmacol Ther 2020;52:233-46. [PMID: 32562590 DOI: 10.1111/apt.15818] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
2 Turco R, Salvatore S, Miele E, Romano C, Marseglia GL, Staiano A. Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics. Ital J Pediatr 2018;44:53. [PMID: 29764491 DOI: 10.1186/s13052-018-0495-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
3 Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:17-44. [DOI: 10.14309/ajg.0000000000001036] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 23.5] [Reference Citation Analysis]
4 Zhang Y, Feng L, Wang X, Fox M, Luo L, Du L, Chen B, Chen X, He H, Zhu S, Hu Z, Chen S, Long Y, Zhu Y, Xu L, Deng Y, Misselwitz B, Lang BM, Yilmaz B, Kim JJ, Owyang C, Dai N. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.Am J Clin Nutr. 2021;. [PMID: 33740048 DOI: 10.1093/ajcn/nqab005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tuck CJ, De Palma G, Takami K, Brant B, Caminero A, Reed DE, Muir JG, Gibson PR, Winterborn A, Verdu EF, Bercik P, Vanner S. Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research. Sci Rep 2020;10:17784. [PMID: 33082369 DOI: 10.1038/s41598-020-74460-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 O'Malley D. Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome. Exp Physiol 2019;104:3-10. [PMID: 30444291 DOI: 10.1113/EP087443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 El-Haggar SM, Hegazy SK, M Abd-Elsalam S, Bahaa MM. Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. J Clin Pharm Ther 2021. [PMID: 34726293 DOI: 10.1111/jcpt.13556] [Reference Citation Analysis]
8 Laatikainen R, Jalanka J, Loponen J, Hongisto SM, Hillilä M, Koskenpato J, Korpela R, Salonen A. Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. BMC Nutr 2019;5:12. [PMID: 32153925 DOI: 10.1186/s40795-019-0278-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Duncanson K, Burrows T, Keely S, Potter M, Das G, Walker M, Talley NJ. The Alignment of Dietary Intake and Symptom-Reporting Capture Periods in Studies Assessing Associations between Food and Functional Gastrointestinal Disorder Symptoms: A Systematic Review. Nutrients 2019;11:E2590. [PMID: 31661839 DOI: 10.3390/nu11112590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Brown SC, Whelan K, Gearry RB, Day AS. Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review. JGH Open 2020;4:153-9. [PMID: 32280758 DOI: 10.1002/jgh3.12231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
11 Illescas O, Rodríguez-Sosa M, Gariboldi M. Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies. Nutrients 2021;13:2234. [PMID: 34209683 DOI: 10.3390/nu13072234] [Reference Citation Analysis]
12 Rej A, Aziz I, Sanders DS. Breaking bread! Proc Nutr Soc 2019;78:118-25. [DOI: 10.1017/s0029665118002549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
13 Mazzawi T, Eikrem Ø, Lied GA, Hausken T. Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation. Gastroenterol Res Pract 2020;2020:3520686. [PMID: 32089675 DOI: 10.1155/2020/3520686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 El-Haggar SM, Hegazy SK, Abd-Elsalam SM, Bahaa MM. Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. Biomed Pharmacother 2022;145:112399. [PMID: 34775240 DOI: 10.1016/j.biopha.2021.112399] [Reference Citation Analysis]
15 Rossi M, Aggio R, Staudacher HM, Lomer MC, Lindsay JO, Irving P, Probert C, Whelan K. Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2018;16:385-391.e1. [PMID: 28993261 DOI: 10.1016/j.cgh.2017.09.055] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
16 Yan R, Andrew L, Marlow E, Kunaratnam K, Devine A, Dunican IC, Christophersen CT. Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review. Nutrients 2021;13:2159. [PMID: 34201752 DOI: 10.3390/nu13072159] [Reference Citation Analysis]
17 Sun Q, Jia Q, Song L, Duan L. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e14513. [PMID: 30762787 DOI: 10.1097/md.0000000000014513] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
18 Dale HF, Jensen C, Hausken T, Valeur J, Hoff DAL, Lied GA. Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients 2019;11:E1635. [PMID: 31319590 DOI: 10.3390/nu11071635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Erdrich S, Hawrelak JA, Myers SP, Harnett JE. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therap Adv Gastroenterol 2020;13:1756284820977402. [PMID: 33343707 DOI: 10.1177/1756284820977402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Staudacher HM, Whelan K. The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66:1517-1527. [PMID: 28592442 DOI: 10.1136/gutjnl-2017-313750] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 26.8] [Reference Citation Analysis]
21 Altomare A, Di Rosa C, Imperia E, Emerenziani S, Cicala M, Guarino MPL. Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients 2021;13:1506. [PMID: 33946961 DOI: 10.3390/nu13051506] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Pietrzak A, Skrzydło-Radomańska B, Mulak A, Lipiński M, Małecka-Panas E, Reguła J, Rydzewska G. Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik. Prz Gastroenterol 2018;13:259-88. [PMID: 30581501 DOI: 10.5114/pg.2018.78343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Barrea L, Muscogiuri G, Annunziata G, Laudisio D, Pugliese G, Salzano C, Colao A, Savastano S. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course? Hormones 2019;18:245-50. [DOI: 10.1007/s42000-019-00100-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
24 Pauls RN, Max JB. Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a USA national survey. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.18.02518-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
25 Verhoog S, Taneri PE, Roa Díaz ZM, Marques-Vidal P, Troup JP, Bally L, Franco OH, Glisic M, Muka T. Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review. Nutrients 2019;11:E1565. [PMID: 31336737 DOI: 10.3390/nu11071565] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
26 Singh P, Nee J. Role of Diet in Diarrhea-predominant Irritable Bowel Syndrome. J Clin Gastroenterol 2021;55:25-9. [PMID: 33060435 DOI: 10.1097/MCG.0000000000001445] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412-431 [DOI: 10.3748/wjg.v28.i4.412] [Reference Citation Analysis]
28 Harer KN, Eswaran SL. Irritable Bowel Syndrome: Food as a Friend or Foe? Gastroenterol Clin North Am 2021;50:183-99. [PMID: 33518164 DOI: 10.1016/j.gtc.2020.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zhao R, Wang Y, Huang Y, Cui Y, Xia L, Rao Z, Zhou Y, Wu X. Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients: A prospective randomized and controlled trial. Medicine (Baltimore) 2017;96:e8418. [PMID: 29069041 DOI: 10.1097/MD.0000000000008418] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
30 Mehtab W, Agarwal A, Singh N, Malhotra A, Makharia GK. All that a physician should know about FODMAPs. Indian J Gastroenterol 2019;38:378-90. [PMID: 31802437 DOI: 10.1007/s12664-019-01002-0] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
31 Dale HF, Biesiekierski JR, Lied GA. Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders: an updated overview. Nutr Res Rev 2019;32:28-37. [PMID: 30009718 DOI: 10.1017/S095442241800015X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
32 Eswaran S, Farida JP, Green J, Miller JD, Chey WD. Nutrition in the management of gastrointestinal diseases and disorders: the evidence for the low FODMAP diet. Curr Opin Pharmacol. 2017;37:151-157. [PMID: 29156449 DOI: 10.1016/j.coph.2017.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
33 Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther 2018;35:289-310. [PMID: 29498019 DOI: 10.1007/s12325-018-0673-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 17.8] [Reference Citation Analysis]
34 Yan R, Murphy M, Genoni A, Marlow E, Dunican IC, Lo J, Andrew L, Devine A, Christophersen CT. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.BMJ Open Gastroenterol. 2020;7. [PMID: 32816830 DOI: 10.1136/bmjgast-2020-000448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Gibson PR, Halmos EP, So D, Yao CK, Varney JE, Muir JG. Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey. J Gastroenterol Hepatol 2022. [PMID: 34994019 DOI: 10.1111/jgh.15772] [Reference Citation Analysis]
36 Mitchell H, Porter J, Gibson PR, Barrett J, Garg M. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment Pharmacol Ther. 2019;49:124-139. [PMID: 30589971 DOI: 10.1111/apt.15079] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
37 Kamal A, Pimentel M. Influence of Dietary Restriction on Irritable Bowel Syndrome. Am J Gastroenterol 2019;114:212-20. [PMID: 30315281 DOI: 10.1038/s41395-018-0241-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
38 Wang XJ, Camilleri M, Vanner S, Tuck C. Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction. Aliment Pharmacol Ther 2019;50:517-29. [DOI: 10.1111/apt.15419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Chen BR, Du LJ, He HQ, Kim JJ, Zhao Y, Zhang YW, Luo L, Dai N. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model. World J Gastroenterol 2017; 23(47): 8321-8333 [PMID: 29307992 DOI: 10.3748/wjg.v23.i47.8321] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
40 Kang D, Ham HI, Lee SH, Cho YJ, Kim YR, Yoon CK, Seok YJ. Functional dissection of the phosphotransferase system provides insight into the prevalence of Faecalibacterium prausnitzii in the host intestinal environment. Environ Microbiol 2021;23:4726-40. [PMID: 34296500 DOI: 10.1111/1462-2920.15681] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc 2021;80:19-28. [PMID: 32468985 DOI: 10.1017/S0029665120006990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
42 Alfaro-Cruz L, Heitkemper M, Chumpitazi BP, Shulman RJ. Literature Review: Dietary Intervention Adherence and Adherence Barriers in Functional Gastrointestinal Disorder Studies. J Clin Gastroenterol 2020;54:203-11. [PMID: 31714332 DOI: 10.1097/MCG.0000000000001280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract 2021;15:411-30. [PMID: 34349876 DOI: 10.4162/nrp.2021.15.4.411] [Reference Citation Analysis]
44 Fukui H, Nishida A, Matsuda S, Kira F, Watanabe S, Kuriyama M, Kawakami K, Aikawa Y, Oda N, Arai K, Matsunaga A, Nonaka M, Nakai K, Shinmura W, Matsumoto M, Morishita S, Takeda AK, Miwa H. Usefulness of Machine Learning-Based Gut Microbiome Analysis for Identifying Patients with Irritable Bowels Syndrome. J Clin Med 2020;9:E2403. [PMID: 32727141 DOI: 10.3390/jcm9082403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
45 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 20.0] [Reference Citation Analysis]
46 Naseri K, Dabiri H, Rostami-Nejad M, Yadegar A, Houri H, Olfatifar M, Sadeghi A, Saadati S, Ciacci C, Iovino P, Zali MR. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterol 2021;21:292. [PMID: 34261437 DOI: 10.1186/s12876-021-01868-5] [Reference Citation Analysis]
47 Algera J, Colomier E, Simrén M. The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients 2019;11:E2162. [PMID: 31505870 DOI: 10.3390/nu11092162] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
48 Fagoonee S, Pellicano R. Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome? J Clin Med 2019;8:E1808. [PMID: 31671546 DOI: 10.3390/jcm8111808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
49 Ibrahim F, Stribling P. A 5Ad Dietary Protocol for Functional Bowel Disorders. Nutrients 2019;11:E1938. [PMID: 31426496 DOI: 10.3390/nu11081938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Vanner S, Whelan K. Fermentable carbohydrates in functional bowel disorders: new insights. J Hum Nutr Diet 2019;32:411-2. [PMID: 31317615 DOI: 10.1111/jhn.12688] [Reference Citation Analysis]
51 Mazzawi T, Lied GA, Sangnes DA, El-Salhy M, Hov JR, Gilja OH, Hatlebakk JG, Hausken T. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLoS One 2018;13:e0194904. [PMID: 30427836 DOI: 10.1371/journal.pone.0194904] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
52 Armour M, Middleton A, Lim S, Sinclair J, Varjabedian D, Smith CA. Dietary Practices of Women with Endometriosis: A Cross-Sectional Survey. J Altern Complement Med 2021. [PMID: 34161144 DOI: 10.1089/acm.2021.0068] [Reference Citation Analysis]
53 So D, Gibson PR, Muir JG, Yao CK. Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine. Gut 2021;70:2383-94. [PMID: 34417199 DOI: 10.1136/gutjnl-2021-324891] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Mazzawi T, El-Salhy M. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med 2017;40:943-52. [PMID: 28849091 DOI: 10.3892/ijmm.2017.3096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
55 Eswaran S. Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies. Neurogastroenterol Motil 2017;29:e13055. [DOI: 10.1111/nmo.13055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
56 Fodor I, Man SC, Dumitrascu DL. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet in children. World J Clin Cases 2019; 7(18): 2666-2674 [PMID: 31616683 DOI: 10.12998/wjcc.v7.i18.2666] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Goyal O, Batta S, Nohria S, Kishore H, Goyal P, Sehgal R, Sood A. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial. J Gastroenterol Hepatol 2021;36:2107-15. [PMID: 33464683 DOI: 10.1111/jgh.15410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
58 Goll R, Johnsen PH, Hjerde E, Diab J, Valle PC, Hilpusch F, Cavanagh JP. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome. Gut Microbes 2020;12:1794263. [PMID: 32991818 DOI: 10.1080/19490976.2020.1794263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current Opinion in Clinical Nutrition & Metabolic Care 2017;20:456-63. [DOI: 10.1097/mco.0000000000000416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
60 Rej A, Shaw CC, Buckle RL, Trott N, Agrawal A, Mosey K, Sanders K, Allen R, Martin S, Newton A, Robinson K, Elphick D, Chey WD, Aziz I, Sanders DS. The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up. Dig Liver Dis 2021:S1590-8658(21)00247-4. [PMID: 34083153 DOI: 10.1016/j.dld.2021.05.004] [Reference Citation Analysis]
61 Aranburu E, Matias S, Simón E, Larretxi I, Martínez O, Bustamante MÁ, Fernández-Gil MDP, Miranda J. Gluten and FODMAPs Relationship with Mental Disorders: Systematic Review. Nutrients 2021;13:1894. [PMID: 34072914 DOI: 10.3390/nu13061894] [Reference Citation Analysis]
62 Shin A, Preidis GA, Shulman R, Kashyap PC. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol 2019;17:256-74. [PMID: 30153517 DOI: 10.1016/j.cgh.2018.08.054] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
63 Hang L, Zhou Y, Meng YY, Feng Y, Wang YS, Yuan JY. Progress in understanding of relationship between short chain fatty acids and irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2021; 29(19): 1102-1109 [DOI: 10.11569/wcjd.v29.i19.1102] [Reference Citation Analysis]
64 Liu T, Gu X, Li LX, Li M, Li B, Cui X, Zuo XL. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients. BMC Microbiol. 2020;20:168. [PMID: 32552668 DOI: 10.1186/s12866-020-01841-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
65 Halmos EP, Biesiekierski JR, Newnham ED, Burgell RE, Muir JG, Gibson PR. Inaccuracy of patient-reported descriptions of and satisfaction with bowel actions in irritable bowel syndrome. Neurogastroenterol Motil. 2018;30. [PMID: 28799291 DOI: 10.1111/nmo.13187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Chey WD, Keefer L, Whelan K, Gibson PR. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology 2021;160:47-62. [PMID: 33091411 DOI: 10.1053/j.gastro.2020.06.099] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
67 Hughes RL, Alvarado DA, Swanson KS, Holscher HD. The Prebiotic Potential of Inulin-type Fructans: A Systematic Review. Adv Nutr 2021:nmab119. [PMID: 34555168 DOI: 10.1093/advances/nmab119] [Reference Citation Analysis]
68 Tuck CJ, Vanner SJ. Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions. Neurogastroenterol Motil 2018;30:e13238. [DOI: 10.1111/nmo.13238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
69 Patel NV. "Let Food Be Thy Medicine": Diet and Supplements in Irritable Bowel Syndrome. Clin Exp Gastroenterol 2021;14:377-84. [PMID: 34588791 DOI: 10.2147/CEG.S321054] [Reference Citation Analysis]
70 Dolan R, Chey WD, Eswaran S. The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs. Expert Rev Gastroenterol Hepatol 2018;12:607-15. [PMID: 29764234 DOI: 10.1080/17474124.2018.1476138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
71 Halmos EP, Gibson PR. Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.J Gastroenterol Hepatol. 2019;34:1134-1142. [PMID: 30945376 DOI: 10.1111/jgh.14650] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
72 Pensabene L, Salvatore S, Turco R, Tarsitano F, Concolino D, Baldassarre ME, Borrelli O, Thapar N, Vandenplas Y, Staiano A, Saps M. Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge. Jornal de Pediatria 2019;95:642-56. [DOI: 10.1016/j.jped.2019.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Laatikainen R, Koskenpato J, Hongisto SM, Loponen J, Poussa T, Huang X, Sontag-Strohm T, Salmenkari H, Korpela R. Pilot Study: Comparison of Sourdough Wheat Bread and Yeast-Fermented Wheat Bread in Individuals with Wheat Sensitivity and Irritable Bowel Syndrome. Nutrients 2017;9:E1215. [PMID: 29113045 DOI: 10.3390/nu9111215] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
74 van Lanen AS, de Bree A, Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021;60:3505-22. [PMID: 33585949 DOI: 10.1007/s00394-020-02473-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
75 Shulman RJ, Öhman L, Stridsberg M, Cain K, Simrén M, Heitkemper M. Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms. Neurogastroenterol Motil 2019;31:e13486. [PMID: 30298961 DOI: 10.1111/nmo.13486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
76 Vanner S, Whelan K. Fermentable carbohydrates in functional bowel disorders: New insights. Neurogastroenterol Motil 2019;31:e13662. [PMID: 31317649 DOI: 10.1111/nmo.13662] [Reference Citation Analysis]
77 Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome. Dig Dis Sci 2018;63:429-36. [DOI: 10.1007/s10620-017-4893-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
78 Toribio-Mateas M. Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions. Microorganisms 2018;6:E35. [PMID: 29693607 DOI: 10.3390/microorganisms6020035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
79 Nordin E, Brunius C, Landberg R, Hellström PM. FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial. Am J Clin Nutr 2021:nqab337. [PMID: 34617561 DOI: 10.1093/ajcn/nqab337] [Reference Citation Analysis]
80 Mars RAT, Frith M, Kashyap PC. Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic? Gastroenterology 2021;160:538-55. [PMID: 33253687 DOI: 10.1053/j.gastro.2020.10.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
81 Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A, de Bortoli N, Mosca M, Marchi S, Rossi A. Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients 2020;12:E148. [PMID: 31947991 DOI: 10.3390/nu12010148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
82 Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9. [PMID: 28846594 DOI: 10.3390/nu9090940] [Cited by in Crossref: 82] [Cited by in F6Publishing: 61] [Article Influence: 16.4] [Reference Citation Analysis]
83 Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR. Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances. Appl Environ Microbiol 2021;87:e00395-21. [PMID: 33741632 DOI: 10.1128/AEM.00395-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Catassi G, Lionetti E, Gatti S, Catassi C. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients 2017;9:E292. [PMID: 28300773 DOI: 10.3390/nu9030292] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 10.4] [Reference Citation Analysis]
85 Muir JG, Varney JE, Ajamian M, Gibson PR. Gluten-free and low-FODMAP sourdoughs for patients with coeliac disease and irritable bowel syndrome: A clinical perspective. Int J Food Microbiol 2019;290:237-46. [PMID: 30388591 DOI: 10.1016/j.ijfoodmicro.2018.10.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
86 Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med 2019;286:490-502. [DOI: 10.1111/joim.12966] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
87 Watt R, Parkin K, Martino D. The Potential Effects of Short-Chain Fatty Acids on the Epigenetic Regulation of Innate Immune Memory. Challenges 2020;11:25. [DOI: 10.3390/challe11020025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Weynants A, Goossens L, Genetello M, De Looze D, Van Winckel M. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.J Hum Nutr Diet. 2020;33:159-169. [PMID: 31637777 DOI: 10.1111/jhn.12706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]